inotuzumab ozogamicin-dose level 2
B1931030
Approved small_molecule completed
Quick answer
inotuzumab ozogamicin-dose level 2 for Leukemia is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Leukemia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed